-
Expert Answers to Common Questions for Optimizing the Use of CDK4 and CDK6 Inhibitors for Metastatic Breast Cancer
0.25 Credits 
AXISAdam M. Brufsky, MD, PhD, FACP -
Anesthesiology, October 2017 CME
1.00 Credits 
American Society of Anesthesiologists -
Managing CMV in the New Era of Antiviral Therapy: Practical Considerations in the HCT Setting
1.0 Credits 
The Medical College of WisconsinRoy F. Chemaly, MD, MPH, FIDSA, FACP -
Complications After 9-Gauge SVAB
1.00 Credits 
American Roentgen Ray Society -
Updates in HCV Screening and Treatment: Key Issues Impacting OB/GYN Practice
1.0 Credits 
Postgraduate Institute for MedicineNancy S. Reau, MD -
Qualitative Radiogenomics
1.00 Credits American Roentgen Ray Society -
Personalizing Long-Acting Reversible Contraceptive Use: Recommending the Best Option by Asking the Right Questions
0.5 Credits 
Oakstone Publishing, LLCJeffrey T. Jensen, MD, MPH -
Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High...
1.00 Credits 
American Medical Association -
PARP Inhibitors: Advancing Personalized Medicine for Patients with Metastatic Breast Cancer – Appropriate Genetic...
0.75 Credits 
The France Foundation -
Contraception Counseling in Patients With SLE and Other Chronic Medical Conditions Requiring Potentially Teratogenic...
1.00 Credits American Medical Association